Home/MediMabBio/Eunhyuk Chang, D.Phil.
EC

Eunhyuk Chang, D.Phil.

CSO (Chief Strategy Officer)

MediMabBio

MediMabBio Pipeline

DrugIndicationPhase
aTIGIT-IL15 Fusion AntibodyOncologyPre-clinical